Article de revue
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
Meningococcal conjugate vaccines protect individuals directly, but can also confer herd protection by interrupting carriage transmission. We assessed the effects of meningococcal quadrivalent glycoconjugate (MenACWY-CRM) or serogroup B (4CMenB) vaccination on meningococcal carriage rates in 18–24-year-olds.
Auteurs
Langues
- Anglais
Année de publication
2014
Journal
Vaccine
Volume
9960
Type
Article de revue
Catégories
- Prestation de services
Maladies
- Méningite à méningocoques
Pays
- Royaume-Uni
Mots-clés
- Introduction de nouveaux vaccins
Régions de l'OMS
- Région européenne